en
Scientific article
Open access
English

Endothelial glycocalyx degradation in multisystem inflammatory syndrome in children related to COVID-19

Published inJournal of molecular medicine, vol. 100, no. 5, p. 735-746
Publication date2022-05
First online date2022-03-26
Abstract

Multisystem inflammatory syndrome in children (MIS-C) represents a rare but severe complication of severe acute respiratory syndrome coronavirus 2 infection affecting children that can lead to myocardial injury and shock. Vascular endothelial dysfunction has been suggested to be a common complicating factor in patients with coronavirus disease 2019 (COVID-19). This study aims to characterize endothelial glycocalyx degradation in children admitted with MIS-C. We collected blood and urine samples and measured proinflammatory cytokines, myocardial injury markers, and endothelial glycocalyx markers in 17 children admitted with MIS-C, ten of which presented with inflammatory shock requiring intensive care admission and hemodynamic support with vasopressors. All MIS-C patients presented signs of glycocalyx deterioration with elevated levels of syndecan-1 in blood and both heparan sulfate and chondroitin sulfate in the urine. The degree of glycocalyx shedding correlated with tumor necrosis factor-α concentration. Five healthy age-matched children served as controls. Patients with MIS-C presented severe alteration of the endothelial glycocalyx that was associated with disease severity. Future studies should clarify if glycocalyx biomarkers could effectively be predictive indicators for the development of complications in adult patients with severe COVID-19 and children with MIS-C. KEY MESSAGES : Children admitted with MIS-C presented signs of endothelial glycocalyx injury with elevated syndecan-1 and heparan sulfate level. Syndecan-1 levels were associated with MIS-C severity and correlated TNF-α concentration. Syndecan-1 and heparan sulfate may represent potential biomarkers for patients with severe COVID-19 or MIS-C.

eng
Keywords
  • COVID-19
  • Endothelium
  • Glycocalyx
  • Heparan sulfate
  • Inflammation
  • MIS-C
  • Adult
  • Biomarkers
  • COVID-19 / complications
  • Child
  • Glycocalyx / metabolism
  • Heparitin Sulfate / metabolism
  • Humans
  • Syndecan-1 / metabolism
  • Systemic Inflammatory Response Syndrome
  • Tumor Necrosis Factor-alpha / metabolism
Citation (ISO format)
VERALDI, Noemi et al. Endothelial glycocalyx degradation in multisystem inflammatory syndrome in children related to COVID-19. In: Journal of molecular medicine, 2022, vol. 100, n° 5, p. 735–746. doi: 10.1007/s00109-022-02190-7
Main files (1)
Article (Published version)
Secondary files (1)
Identifiers
ISSN of the journal0946-2716
11views
2downloads

Technical informations

Creation08/14/2023 1:27:48 PM
First validation01/29/2024 1:37:03 PM
Update time01/29/2024 1:37:03 PM
Status update01/29/2024 1:37:03 PM
Last indexation02/01/2024 11:22:28 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack